Mark Lennihan
Andrew Witty, CEO of GlaxoSmithKline, speaks at the Council on Foreign Relations, Wednesday, Jan. 20, 2010, in New York. Drugmaker GlaxoSmithKline said Wednesday it will open up its research cupboards and labs to outside scientists in an unusual effort to trigger more research on malaria and other neglected tropical diseases. The London-based company also said its researchers expect in 2012 to be able to seek approval for the first vaccine against malaria, a mosquito-borne parasitic disease that kills a million people a year, mostly young children in Africa. (AP Photo/Mark Lennihan)
